Cytochrome enzyme genotype and the prediction of therapeutic response to psychotropics

被引：5

作者：

Alam, DA ^{[1
]}

Sharma, RP ^{[1
]}

机构：

[1] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA

来源：

PSYCHIATRIC ANNALS | 2001年 / 31卷 / 12期

关键词：

D O I：

10.3928/0048-5713-20011201-07

中图分类号：

R749 [精神病学];

学科分类号：

100205 [精神病与精神卫生学];

摘要：

[No abstract available]

引用

收藏

页码：715 / 722

页数：8

相关论文

共 33 条

[1]

Nonfunctional CYP2D6 alleles and risk for neuroleptics-induced movement disorders in schizophrenic patients [J].

Andreassen, OA ;

MacEwan, T ;

Gulbrandsen, AK ;

McCreadie, RG ;

Steen, VM .

PSYCHOPHARMACOLOGY, 1997, 131 (02) :174-179

[2]

Antipsychotic drug-Induced movement disorders in schizophrenics in relation to CYP2D6 genotype [J].

Armstrong, M ;

Daly, AK ;

Blennerhassett, R ;

Ferrier, N ;

Idle, JR .

BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 :23-26

[3]

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene:: association with tardive dyskinesia in schizophrenia [J].

Basile, VS ;

Özdemir, V ;

Masellis, M ;

Walker, ML ;

Heltzer, HY ;

Lieberman, JA ;

Potkin, SG ;

Alva, G ;

Kalow, W ;

Macciardi, FM ;

Kennedy, JL .

MOLECULAR PSYCHIATRY, 2000, 5 (04) :410-417

[4]

Extension of a pilot study: Impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness [J].

Chou, WH ;

Yan, FX ;

de Leon, J ;

Barnhill, J ;

Rogers, T ;

Cronin, M ;

Pho, M ;

Xiao, V ;

Ryder, TB ;

Liu, WW ;

Teiling, C ;

Wedlund, PJ .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (02) :246-251

[5]

Clinical implications of antidepressant pharmacokinetic and pharmacogenetics [J].

Cohen, LJ ;

DeVane, CL .

ANNALS OF PHARMACOTHERAPY, 1996, 30 (12) :1471-1480

[6]

Variations on a theme: Cataloging human DNA sequence variation [J].

Collins, FS ;

Guyer, MS ;

Chakravarti, A .

SCIENCE, 1997, 278 (5343) :1580-1581

[7]

A DNA polymorphism discovery resource for research on human genetic variation [J].

Collins, FS ;

Brooks, LD ;

Chakravarti, A .

GENOME RESEARCH, 1998, 8 (12) :1229-1231

[8]

Nomenclature for human CYP2D6 alleles [J].

Daly, AK ;

Brockmoller, J ;

Broly, F ;

Eichelbaum, M ;

Evans, WE ;

Gonzalez, FJ ;

Huang, JD ;

Idle, JR ;

IngelmanSundberg, M ;

Ishizaki, T ;

JacqzAigrain, E ;

Meyer, UA ;

Nebert, DW ;

Steen, VM ;

Wolf, CR ;

Zanger, UM .

PHARMACOGENETICS, 1996, 6 (03) :193-201

[9]

Association between cytochrome P4502D6 (CYP2D6) genotype, antipsychotic exposure, and abnormal involuntary movement scale (AIMS) score [J].

Ellingrod, VL ;

Schultz, SK ;

Arndt, S .

PSYCHIATRIC GENETICS, 2000, 10 (01) :9-11

[10]

The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population [J].

Fukuda, T ;

Nishida, Y ;

Zhou, Q ;

Yamamoto, I ;

Kondo, S ;

Azuma, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (02) :175-180

← 1 2 3 4 →